Posts Tagged ‘clinical guidance’

New research published in The Lancet Diabetes & Endocrinology promises to shake up laissez faire attitudes about prediabetes. Elsa Vazquez Arreola and colleagues show, in post-hoc analyses of two landmark diabetes prevention trials, that reversing prediabetes can cut the risk of cardiovascular death or hospitalization by half in diverse populations. This finding, though it comes […]

Today, three of the leading voices for obesity care are releasing new guidance for obesity medicines in ongoing therapy. The Obesity Society, Obesity Medicine Association, and Obesity Action Coalition all came together in support of this important new guidance. Alongside its publication in the journal Obesity, Beverly Tchang and Donna Ryan offer a “humbling call […]

On the opening day of ObesityWeek yesterday, we got quite a treat in a passionate debate of the Lancet Commission report on clinical obesity. Four of our favorite people – Sue Yanovski, Bob Kushner, Fatima Cody Stanford, and Donna Ryan – participated and made it memorable. We walked away with a clear understanding that many […]

“It takes a village to create standards of care,” said Nuha Ali El Sayed as she opened a symposium on the emerging standards of care for obesity. Truer words were never spoken. Defining these standards is tricky. That’s because they they need to reflect both what is desirable and a standard that good health professionals […]

A new viewpoint in JAMA Pediatrics articulates a concern we hear repeatedly about the Lancet Commission on Clinical Obesity. Pediatric obesity experts have reservations about applying the concept of preclinical obesity in pediatrics. Melania Manco is a professor of pediatrics, clinical research scientist, and consultant endocrinologist at the Bambino Gesù Hospital in Rome. She writes: […]

It is really easy to beat up on the lowly BMI. The Lancet Commission on clinical obesity gently kicked it to the curb by saying BMI “can both overestimate and underestimate adiposity” and thus declared its obsolescence as a singular measure for excess adiposity. “Excess adiposity should be confirmed by either direct measurement of body […]

We’ve been living with the consensus report of the Lancet Commission on Clinical Obesity now for two months. Enough time has passed for feelings about the strengths and limitations of this work to take shape. A new commentary in the BMJ yesterday brings a sharp focus to the struggle of defining and dealing with current […]

It would be hard to dispute that we are living in an age of cynicism. Distrust is all around – especially when the subject is health. Thus, it should not be a surprise that consensus about diagnosing obesity turns out to be quite a challenge. And yet, we are surprised that a global consensus on […]

It was easy to see this coming. Our top prediction for the new year was that the Lancet Commission on Clinical Obesity would be big news and the spark for a big debate. The news splash was unmistakable. From 92 countries all over the world, more than 3,000 persons lined up for the launch event. […]

Obesity is linked to many common diseases, such as type 2 diabetes, heart disease, fatty liver disease and knee osteoarthritis. Obesity is currently defined using a person’s body mass index, or BMI. This is calculated as weight (in kilograms) divided by the square of height (in metres). In people of European descent, the BMI for […]